Mary Haak-Frendscho
Director/Board Member bei SURROZEN, INC.
Profil
Mary Haak-Frendscho was the founder of Compugen, Inc. (United States) founded in 2012, where she served as Chairman until 2016.
Currently, she holds multiple positions including President, Chief Executive Officer & Director at Spotlight Therapeutics, Inc. since 2019, Director at Sirenas LLC since 2015, Director at Surrozen Operating, Inc. since 2021, and Independent Director at Surrozen, Inc. since 2021.
Dr. Haak-Frendscho's former positions include Chief Executive Officer & Director at Igenica Biotherapeutics, Inc. from 2012 to 2014, Chief Executive Officer & Director at Blueline Bioscience from 2016 to 2019, and President & Chief Scientific Officer at Takeda California, Inc. from 2008 to 2012.
She also served as a Principal at Genentech, Inc. and Abgenix, Inc., Director at Northern Biologics, Inc., and Chief Scientific Officer, VP-Preclinical R&D at XOMA Corp.
Dr. Haak-Frendscho was a Venture Partner at Versant Ventures Canada Ltd.
from 2017 to 2019.
Dr. Haak-Frendscho's education includes a graduate degree from the University of Washington, a graduate degree from Stony Brook University, a doctorate degree from the University of Wisconsin, and an undergraduate degree from the University of Michigan.
Aktive Positionen von Mary Haak-Frendscho
| Unternehmen | Position | Beginn |
|---|---|---|
| SURROZEN, INC. | Director/Board Member | 01.03.2021 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Director/Board Member | 11.03.2021 |
Spotlight Therapeutics, Inc.
 Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA. | Chief Executive Officer | 01.01.2019 |
Sirenas LLC
 Sirenas LLC Pharmaceuticals: MajorHealth Technology Sirenas LLC research and develops marine inspired pre-clinical leads for cancer, human immunodeficiency virus and infectious diseases. The company was founded by Jake Beverage, Eduardo Esquenazi and Phil Baran and is headquartered in San Diego, CA. | Director/Board Member | 01.10.2015 |
Ehemalige bekannte Positionen von Mary Haak-Frendscho
| Unternehmen | Position | Ende |
|---|---|---|
Blueline Bioscience
 Blueline Bioscience Investment ManagersFinance Blueline Bioscience acts as an alternative investment manager. The company is headquartered in Toronto, Canada. | Chief Executive Officer | 01.01.2019 |
| Versant Ventures Canada Ltd. | Private Equity Investor | 01.01.2019 |
| Compugen, Inc. (United States) | Founder | 01.01.2016 |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Chief Executive Officer | 01.01.2014 |
Takeda California, Inc.
 Takeda California, Inc. Pharmaceuticals: MajorHealth Technology Takeda California, Inc. is a pharmaceutical manufacturing company. The private company is based in San Diego, CA. | President | 01.01.2012 |
Ausbildung von Mary Haak-Frendscho
| University of Washington | Graduate Degree |
| Stony Brook University | Graduate Degree |
| University of Wisconsin | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| XOMA CORPORATION | Health Technology |
| SURROZEN, INC. | Health Technology |
| Private Unternehmen | 11 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
Sirenas LLC
Sirenas LLC Pharmaceuticals: MajorHealth Technology Sirenas LLC research and develops marine inspired pre-clinical leads for cancer, human immunodeficiency virus and infectious diseases. The company was founded by Jake Beverage, Eduardo Esquenazi and Phil Baran and is headquartered in San Diego, CA. | Health Technology |
| Compugen, Inc. (United States) | |
Takeda California, Inc.
Takeda California, Inc. Pharmaceuticals: MajorHealth Technology Takeda California, Inc. is a pharmaceutical manufacturing company. The private company is based in San Diego, CA. | Health Technology |
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Health Services |
Blueline Bioscience
Blueline Bioscience Investment ManagersFinance Blueline Bioscience acts as an alternative investment manager. The company is headquartered in Toronto, Canada. | Finance |
| Versant Ventures Canada Ltd. | Finance |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Health Technology |
Spotlight Therapeutics, Inc.
Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA. | Health Technology |
